Aquestive Therapeutics, Inc. - Common Stock - relatórios financeiros (NASDAQ:AQST) | MetaTrader

Abrir gráfico completo Full chart

Notícias

Citizens mantém recomendação para Aquestive com avanço do Anaphylm

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates

Lucro da Aquestive Therapeutics superou projeções por $0,06; receita supera estimativas

Aquestive obtém linha de crédito de US$ 150 milhões com a Oaktree

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates

Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know

Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Aquestive reafirma reenvio do NDA do Anaphylm para o 3º tri de 2026

Aquestive nomeia Thomas Zalewski como diretor jurídico

Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)